uPA shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

uPA shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
uPA shRNA Plasmid (h)

Product Specs
ItemuPA shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-36779-SH
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Nameplasminogen activator, urokinase
NCBI Gene AliasesATF, BDPLT5, QPD, UPA, URK, u-PA
Quantity20 µg

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Nasal symbiont Staphylococcus epidermidis restricts the cellular entry of influenza virus into the nasal epitheliumNPJ biofilms and microbiomesApril 13, 2022Jo A, Won J, Gil CH, Kim SK, Lee KM, Yoon SS, Kim HJ.

(2) Regulatory effects of estetrol on the endothelial plasminogen pathway and endothelial cell migrationMaturitasMay 1, 2017Montt-Guevara MM, Palla G, Spina S, Bernacchi G, Cecchi E, Campelo AE, Shortrede JE, Canu A, Simoncini T.

(3) Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned mediumScientific reportsNovember 21, 2016Liu P, Weng Y, Sui Z, Wu Y, Meng X, Wu M, Jin H, Tan X, Zhang L, Zhang Y.

(4) Involvement of fibrinolytic regulators in adhesion of monocytes to vascular endothelial cells induced by glycated LDL and to aorta from diabetic miceJournal of leukocyte biologyJune 1, 2014Zhao R, Ren S, Moghadasain MH, Rempel JD, Shen GX.

(5) Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancerMolecular biology of the cellSeptember 1, 2013Asuthkar S, Stepanova V, Lebedeva T, Holterman AL, Estes N, Cines DB, Rao JS, Gondi CS.

(6) High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasisWorld journal of gastroenterologyJanuary 21, 2012Thummarati P, Wijitburaphat S, Prasopthum A, Menakongka A, Sripa B, Tohtong R, Suthiphongchai T.

(7) Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assemblyPloS oneJanuary 1, 2012Wang L, Pedroja BS, Meyers EE, Garcia AL, Twining SS, Bernstein AM.

(8) Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migrationJournal of cellular biochemistryJune 1, 2009Ahmad A, Kong D, Sarkar SH, Wang Z, Banerjee S, Sarkar FH.

(9) Synthesis and characterization of an (111)In-labeled peptide for the in vivo localization of human cancers expressing the urokinase-type plasminogen activator receptor (uPAR)Bioconjugate chemistryMay 20, 2009Liu D, Overbey D, Watkinson L, Giblin MF.

(10) uPA dependent and independent mechanisms of wound healing by C-phycocyaninJournal of cellular and molecular medicineDecember 1, 2008Madhyastha HK, Radha KS, Nakajima Y, Omura S, Maruyama M.

(11) Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancerCancer researchApril 1, 2007Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH.

Be the First to Write a Review!